Ravgen Company
Ravgen is focused on developing non invasive prenatal diagnostic tests, based on fetal DNA present in maternal blood.
Total Funding:
$3,573,315
Headquarters:
Columbia, Maryland, United States
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Debt Financing
Technology:
Pregnancy biomarkers
Last Funding Date:
2021-06-03
Founded Date:
01-01-2000
Industry:
General Health Care